Matthew J. Webber, Keating-Crawford Collegiate Professor of Engineering and associate professor of chemical and biomolecular engineering at the University of Notre Dame, has been inducted as a fellow into the American Institute for Medical and Biological Engineering (AIMBE).
Election to the AIMBE College of Fellows is among the highest professional distinctions awarded to medical and biological engineers.
Webber has pioneered advancements in the application of supramolecular chemistry to prepare functional biomaterials and drug delivery technologies. The Webber Lab approaches the design of materials from the molecular scale, with an emphasis on understanding and exploiting reversible interactions to achieve predictable function. This approach enables the development of materials for use in medicine, such as injectable gels, as well as the design of novel disease therapeutics that offer more precise, on-demand dosing.
AIMBE Fellows are among the most distinguished medical and biological engineers. They include 3 Nobel Prize laureates and 17 recipients of the Presidential Medal of Science and/or Technology and Innovation, as well as 205 members of the National Academy of Engineering, 105 of the National Academy of Medicine, and 43 of the National Academy of Sciences.
“It is an honor to have been elected by my peers,” said Webber. “As the first AIMBE fellow at Notre Dame, I am especially excited about the opportunity to connect our University with this great organization in advocating for continued support of biomedical research in the United States.”
Webber joined the Notre Dame faculty in 2016. He holds a bachelor’s degree in chemical engineering from Notre Dame and a doctoral degree in biomedical engineering from Northwestern University. He completed his research training as a postdoctoral fellow at the Massachusetts Institute of Technology.